These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15186567)

  • 21. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.
    Trinks J; Cuestas ML; Tanaka Y; Mathet VL; Minassian ML; Rivero CW; Benetucci JA; Gímenez ED; Segura M; Bobillo MC; Corach D; Ghiringhelli PD; Sánchez DO; Avila MM; Peralta LA; Kurbanov F; Weissenbacher MC; Simmonds P; Mizokami M; Oubiña JR
    J Viral Hepat; 2008 Nov; 15(11):827-38. PubMed ID: 18507755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
    J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician practices regarding adult hepatitis B vaccination: a national survey.
    Daley MF; Hennessey KA; Weinbaum CM; Stokley S; Hurley LP; Crane LA; Beaty BL; Barrow JC; Babbel CI; Dickinson LM; Kempe A
    Am J Prev Med; 2009 Jun; 36(6):491-6. PubMed ID: 19362798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands.
    van Houdt R; Sonder GJ; Dukers NH; Bovee LP; van den Hoek A; Coutinho RA; Bruisten SM
    Vaccine; 2007 Mar; 25(14):2698-705. PubMed ID: 16919856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B vaccination in prisons.
    Awofeso N
    Bull World Health Organ; 2002; 80(7):569-74. PubMed ID: 12163921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Difficult to motivate intravenous addicts for vaccination against hepatitis. The campaign in Blekinge was not successful: it reached only 10 percent of the group].
    Eitrem R
    Lakartidningen; 2003 Feb; 100(6):424-6. PubMed ID: 12607435
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B immunity in a population of drug and alcohol users.
    Polizzotto MN; Whelan G
    Drug Alcohol Rev; 2007 Jul; 26(4):417-9. PubMed ID: 17564878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of perceptions of hepatitis B and C status. Injecting drug users need vaccination against hepatitis B.
    Ramsay ME; Balogun MA; Teo CG; Mortimer PP
    BMJ; 2000 Feb; 320(7233):512; author reply 513. PubMed ID: 10678875
    [No Abstract]   [Full Text] [Related]  

  • 31. Coverage of hepatitis B vaccination in Swedish healthcare workers.
    Dannetun E; Tegnell A; Torner A; Giesecke J
    J Hosp Infect; 2006 Jun; 63(2):201-4. PubMed ID: 16621139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis vaccination among drug users.
    Quaglio G; Lugoboni F; Mezzelani P; Des Jarlais DC; Lechi A
    Vaccine; 2006 Apr; 24(15):2702-9. PubMed ID: 16436307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are primary health care centres that target injecting drug users attracting and serving the clients they are designed for? A case study from Sydney, Australia.
    Islam MM; Topp L; Conigrave KM; White A; Haber PS; Day CA
    Int J Drug Policy; 2013 Jul; 24(4):326-32. PubMed ID: 22818978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatitis B and C risk factors in Germany--results of the national surveillance].
    Walter J; Radun D; Claus H; Hamouda O; Stark K
    Gesundheitswesen; 2005 Jul; 67(7):441-7. PubMed ID: 16103966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy "don't ask, draw a blood sample, vaccinate and try to schedule another visit".
    de la Fuente L; Toro C; Brugal MT; Vallejo F; Soriano V; Barrio G; Ballesta R; Bravo MJ;
    J Clin Virol; 2007 Jan; 38(1):87-90. PubMed ID: 17088099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users.
    Kuo I; Mudrick DW; Strathdee SA; Thomas DL; Sherman SG
    Clin Infect Dis; 2004 Feb; 38(4):587-90. PubMed ID: 14765355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ
    Vaccine; 2006 Mar; 24(13):2377-86. PubMed ID: 16384627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006.
    Giraudon I; Permalloo N; Nixon G; Charlett A; Cohuet S; Mandal S; Ramsay M; Patel BC; Maguire H
    Vaccine; 2009 Mar; 27(14):2016-22. PubMed ID: 19135494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.